Rahmer Peter (CIK 1959229) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-28). Recent activity: Sell RLAY (4,508 shares), Sell RLAY (748 shares), Sell RLAY (50,000 shares), Buy RLAY (3,056 shares), Sell RLAY (753 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 4,508 | $90,295 |
| 2026-07-30 | Relay Therapeutics, Inc. (RLAY) | See remarks | Sell | 748 | $13,920 |
| 2026-07-02 | Relay Therapeutics, Inc. (RLAY) | See remarks | Sell | 50,000 | $954,500 |
| 2026-07-02 | Relay Therapeutics, Inc. (RLAY) | See remarks | Buy | 3,056 | $21,239 |
| 2026-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 753 | $11,137 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Buy | 994 | $2,972 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 11,684 | $89,032 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 1,354 | $11,441 |
| 2025-10-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 19,135 | $139,494 |
| 2025-10-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 21,394 | $160,455 |
| 2025-07-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Develpment Officer | Sell | 1,359 | $5,083 |
| 2025-07-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Develpment Officer | Sell | 15,724 | $57,864 |
| 2025-07-01 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Develpment Officer | Buy | 5,000 | $14,700 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 1,364 | $4,324 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Corporate Development Officer | Sell | 10,739 | $32,217 |
来源：SEC Form 4 申报文件 · 截至 2026-08-28